SCHEMBL9526174

SCHEMBL9526174

COc1ccc(S(=O)(=O)NC(=O)Nc2ccc(Cl)cc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPIA P62937 1/20 0.64
EGFR P00533 1/20 0.62
ERBB2 P04626 1/20 0.62
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
HSD17B10 Q99714 1/20 0.59
PPARG P37231 1/20 0.58
IDH1 O75874 1/20 0.58
NPC1 O15118 2/20 0.58
FLT1 P17948 2/20 0.57
FLT4 P35916 2/20 0.57
KDR P35968 2/20 0.57
POLB P06746 1/20 0.57
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA9 Q16790 1/20 0.57
HRH3 Q9Y5N1 1/20 0.57
RAB9A P51151 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6467685 0.89 HSD17B10 (0.61) MEN1KMT2AHSD17B10PPARGNPC1
SCHEMBL9486495 0.88 CA12 (0.66) MEN1KMT2APPARGFLT1FLT4
SCHEMBL5187356 0.87 CA12 (0.70) EGFRMEN1KMT2AHSD17B10PPARG
SCHEMBL9526067 0.86 POLB (0.76) EGFRERBB2MEN1KMT2AHSD17B10
SCHEMBL8621686 0.86 LMNA (0.62) EGFRERBB2MEN1KMT2AHSD17B10
SCHEMBL7777663 0.86 LMNA (0.71) EGFRERBB2HSD17B10NPC1POLB
SCHEMBL9485899 0.85 CYP3A4 (0.55) MEN1KMT2AHSD17B10POLBCA12
SCHEMBL8662949 0.85 HRH3 (0.72) HSD17B10NPC1POLBCA12CA1
SCHEMBL6467353 0.85 SAE1 (0.71) EGFRERBB2HSD17B10NPC1POLB
SCHEMBL9485939 0.84 FLT1 (0.62) MEN1KMT2AIDH1FLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0166615-B1 IMPROVEMENTS IN OR RELATING TO BENZENESULFONAMIDO DERIVATIVES ELI LILLY AND COMPANY (US) 1993-05-26 EP disclosed
US-5110830-A Benzenesulfonamides treatment of tumors susceptible to ELI LILLY AND COMPANY (US) 1992-05-05 US disclosed
US-4845128-A ANTITUMOR ELI LILLY AND COMPANY (US) 1989-07-04 US disclosed
EP-0166615-A2 Improvements in or relating to benzenesulfonamido derivatives ELI LILLY AND COMPANY (US) 1986-01-02 EP disclosed